Amr has over 30 years of healthcare experience and is the founder and CEO of Shifamed LLC. He has held leadership roles at portfolio companies, including Embolic Protection Inc.
Eric has over 20 years of experience in medical device operations, leading operations, quality, and engineering from concept through post-market for Class II and Class III technologies.
Faisal has over 15 years of medical device experience, including leading the global commercialization of ReCor’s system to treat hypertension before joining Akura.
Joann has over 30 years of medical device experience. At Guidant Vascular, Joann held manufacturing and R&D positions before moving to sales in Guidant’s cardiac rhythm organization, where Joann provided technical support for pacemakers, defibrillators, and cardiac resynchronization devices.
Akura Medical is a medical technology company focused on venous thromboembolism (VTE). Its flagship product is the Katana Thrombectomy System, and the company aims to improve outcomes and quality of life for people with VTE.
The Katana Thrombectomy System is not cleared for sale in the United States or approved for sale in any country. The page states that up to 900,000 people in the United States are affected by venous thromboembolism each year.
Akura Medical, Inc.’s privacy notice, last updated June 10, 2024, applies to personal information processed through its websites and other online offerings.